.international
http://lm360.us/Dekoning-mother-of-Dresch-from-Meythet?Daversaso=255
.
. eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
explore xinhuanet
-
.
.